Clincosm LogoSign in Get a demo

SCLC

Showing 1 - 25 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Online Adaptive Radiotherapy UsingNovel Linear Accelerator

Recruiting
  • Prostate Cancer
  • +8 more
  • Online adaptive radiation therapy
  • Berlin, Germany
    Charité - Universitätsmedizin
Oct 30, 2023

Safety and Efficacy of Zepzelca™ Injection

Recruiting
  • SCLC
    • Seoul, Korea, Republic of
      Seoul National University Boramae Medical Center
    Aug 28, 2023

    Small Cell Lung Cancer, SCLC, Extensive Stage Small Cell Lung Cancer Trial (Durvalumab, Monalizumab, Carboplatin or Cisplatin)

    Not yet recruiting
    • Small Cell Lung Cancer
    • +2 more
    • (no location specified)
    Jun 5, 2023

    SCLC Trial in Changchun (PM8002, Paclitaxel)

    Recruiting
    • SCLC
    • Changchun, China
      Jilin Provincial Tumor Hospital
    May 25, 2023

    SCLC Trial (PM8002, Platinum, Atezolizumab)

    Not yet recruiting
    • SCLC
    • (no location specified)
    May 4, 2023

    Advanced Breast Cancer, Treatment-Refractory Solid Tumors, Retinoblastoma Deficiency Trial in Providence (Palbociclib Oral

    Not yet recruiting
    • Advanced Breast Cancer
    • +6 more
    • Providence, Rhode Island
      Lifespan Cancer Institute
    Feb 1, 2023

    HRD Cancer, SCLC, Advanced Solid Tumors Trial run by the NCI (Berzosertib, Sacituzumab Govitecan)

    Recruiting
    • HRD Cancer
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)

    Recruiting
    • SCLC
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Lung Cancer, SCLC Trial in United States (Nivolumab, Plinabulin, Ipilimumab)

    Recruiting
    • Lung Cancer
    • SCLC
    • Duarte, California
    • +7 more
    Jan 18, 2023

    Phase 1, NSCLC, SCLC Trial in United States (Oral MRT-2359)

    Recruiting
    • NSCLC
    • +6 more
    • Oral MRT-2359
    • Scottsdale, Arizona
    • +7 more
    Dec 20, 2022

    Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,

    Recruiting
    • Advanced Solid Tumors
    • +11 more
    • Boston, Massachusetts
    • +4 more
    Dec 12, 2022

    SCLC Trial in Shanghai (Carboplatin, Cisplatin, Etoposide)

    Active, not recruiting
    • SCLC
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Jul 18, 2022

    SCLC Trial in United States (Nivatrotamab)

    Terminated
    • SCLC
    • Tampa, Florida
    • +6 more
    Jul 11, 2022

    SCLC, Malignant Melanoma, Sarcoma Trial (GD2-SADA:177Lu-DOTA Complex)

    Not yet recruiting
    • SCLC
    • +2 more
    • GD2-SADA:177Lu-DOTA Complex
    • (no location specified)
    May 4, 2022

    NSCLC, SCLC, CRPC Trial in Tianjin (JAB-8263)

    Recruiting
    • NSCLC
    • +7 more
    • Tianjin, Tianjin, China
      Tianjin
    Mar 11, 2022

    Small-cell Lung Cancer, SCLC, Small Cell Lung Cancer Limited Stage Trial in Baltimore (Hippocampal-sparing Prophylactic Cranial

    Completed
    Has Results
    • Small-cell Lung Cancer
    • +2 more
    • Hippocampal-sparing Prophylactic Cranial Irradiation
    • Baltimore, Maryland
    • +1 more
    Sep 22, 2021

    SCLC, NSCLC Trial (MILs™ in Combination with Pembrolizumab)

    Withdrawn
    • SCLC
    • NSCLC
    • MILs™ in Combination with Pembrolizumab
    • (no location specified)
    Oct 1, 2021

    SCLC, Brain Metastases Trial in Heidelberg (SRS, WBRT)

    Recruiting
    • SCLC
    • Brain Metastases
    • SRS
    • WBRT
    • Heidelberg, Germany
      University Hospital of Heidelberg, Department of Radiation Oncol
    Sep 28, 2021

    SCLC Trial in Shanghai (Conventionally fractionated concurrent chemo-radiotherapy, Accelerated hypofractionated concurrent

    Recruiting
    • SCLC
    • Conventionally fractionated concurrent chemo-radiotherapy
    • Accelerated hypofractionated concurrent chemo-radiotherapy
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Apr 26, 2021

    SCLC Trial in Seoul (AZD6738, Olaparib)

    Completed
    • SCLC
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Feb 16, 2021

    SCLC, Anlotinib Trial in Shanghai (Anlotinib HCl, Etoposide, Carboplatin)

    Unknown status
    • SCLC
    • Anlotinib
    • Anlotinib hydrochloride
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Chest hospital
    Dec 22, 2020

    SCLC Trial in Seoul (Pazopanib, Placebo)

    Completed
    • SCLC
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Dec 5, 2019

    NSCLC, Squamous NSCLC, NSCLC Trial in Worldwide (Lucitanib)

    Terminated
    • Non-Small Cell Lung Cancer
    • +8 more
    • Los Angeles, California
    • +18 more
    Jul 22, 2019

    Small Cell Lung Cancer, Lung Cancer, SCLC Trial in Boston (Pazopanib)

    Completed
    Has Results
    • Small Cell Lung Cancer
    • +2 more
    • Boston, Massachusetts
    • +2 more
    Apr 12, 2019

    Next-generation Sequencing of Small Cell Lung Cancer to Identify

    Unknown status
    • SCLC
      • (no location specified)
      Aug 5, 2017